Program Detail

Modality
Program #
Program indication
Presentation

Source
Respiratory syncytial virus (RSV) vaccine

Last updated Dec 06, 2018

Source
Cytomegalovirus (CMV) vaccine

Last updated Dec 06, 2018

Source
Human metapneumovirus and \nparainfluenza virus 3 (hMPV+PIV3) vaccine

Last updated Dec 06, 2018

Source
Varicella zoster virus \n\i(VZV) vaccine/i

Last updated Dec 06, 2018

Source
Influenza H10N8 vaccine

Last updated Dec 06, 2018

Source
Influenza H7N9 vaccine

Last updated Dec 06, 2018

Source
Zika vaccine

Last updated Dec 06, 2018

Source
Zika vaccine

Last updated Dec 06, 2018

Source
Chikungunya vaccine

Last updated Dec 06, 2018

Source
Personalized Cancer Vaccine (PCV) \n\iSolid tumors/i

Last updated Dec 06, 2018

Source
KRAS vaccine \n\iCRC, NSCLC, pancreatic cancer/i

Last updated Dec 06, 2018

Source
OX40L \n\iSolid tumors/lymphoma/i\n\iAdvanced ovarian carcinoma/i

Last updated Jan 08, 2019

Source
OX40L+IL23+IL36γ \n\iSolid tumors/lymphoma/i

Last updated Jan 08, 2019

Source
IL12 \n\iSolid tumors/i

Last updated Dec 06, 2018

Source
VEGF-A \n\iMyocardial ischemia/i

Last updated Dec 06, 2018

Source
Antibody against Chikungunya virus

Last updated Dec 06, 2018

Source
Relaxin \n\iHeart failure/i

Last updated Dec 06, 2018

Source
α-GAL \n\iFabry disease/i

Last updated Dec 06, 2018

Source
MUT \n\iMethylmalonic acidemia (MMA)/i

Last updated Jan 08, 2019

Source
PCCA+PCCB \n\iPropionic acidemia (PA)/i

Last updated Dec 06, 2018

Source
PAH \n\iPhenylketonuria (PKU)/i

Last updated Dec 06, 2018